University of Oxford
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After Chemotherapy
- Conditions
- Adenocarcinoma of the Gastroesophageal JunctionEsophageal Cancer
- Interventions
- Procedure: quality-of-life assessment
- First Posted Date
- 2010-11-18
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 450
- Registration Number
- NCT01243398
- Locations
- 🇬🇧
New Cross Hospital, Wolverhampton, England, United Kingdom
Thymoglobulin Induction in Kidney Transplant Recipients
- Conditions
- Kidney TransplantationIschemia-Reperfusion Injury
- Interventions
- Drug: antithymocyte globulin
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2010-11-11
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT01239563
- Locations
- 🇬🇧
Oxford Transplant Centre, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
🇬🇧University of Oxford, Oxford, Oxfordshire, United Kingdom
Swine Flu (Influenza A H1N1) Follow on Vaccine Study
- Conditions
- Influenza
- Interventions
- Drug: Seasonal Flu vaccine
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2017-12-08
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 560
- Registration Number
- NCT01239537
- Locations
- 🇬🇧
Bristol Children's Vaccine Centre, University of Bristol, Bristol, United Kingdom
🇬🇧St George's Vaccine Institute, University of London, London, United Kingdom
🇬🇧Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom
Pharmacokinetic Study of Primaquine and Chloroquine in Healthy Subjects
- Conditions
- Vivax Malaria
- Interventions
- Drug: ADrug: B
- First Posted Date
- 2010-10-11
- Last Posted Date
- 2012-06-14
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 16
- Registration Number
- NCT01218932
- Locations
- 🇹🇭
Hospital For Tropical Diseases, Bangkok, Thailand
The Efficacy of Viscosupplementation for Early Knee Osteoarthritis
- Conditions
- Knee Osteoarthritis
- Interventions
- Device: Synvisc OneOther: Routine management
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2012-06-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 60
- Registration Number
- NCT01210742
- Locations
- 🇬🇧
Nuffield Orthopaedic Centre, Biomedical Research Unit (BRU), Oxford, England, United Kingdom
A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A
- Conditions
- Tuberculosis
- First Posted Date
- 2010-09-02
- Last Posted Date
- 2012-08-30
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 48
- Registration Number
- NCT01194180
- Locations
- 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxon, United Kingdom
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route
- Conditions
- Tuberculosis
- Interventions
- Biological: MVA 85A
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 24
- Registration Number
- NCT01181856
- Locations
- 🇬🇧
Centre of Clinical Vaccinology and Tropical Medicine (CCVTM) Churchill Hospital, Oxford, United Kingdom
Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan
- First Posted Date
- 2010-08-09
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 593
- Registration Number
- NCT01178021
- Locations
- 🇦🇫
Provincial Malaria Control Centers (MRC), Kunduz, Afghanistan
Intravitreal Macugen for Ischaemic Diabetic Macular Oedema
- Conditions
- Diabetic Macular Oedema
- Interventions
- Drug: Intravitreal injection of pegaptanib sodium
- First Posted Date
- 2010-08-04
- Last Posted Date
- 2014-12-24
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 30
- Registration Number
- NCT01175070
- Locations
- 🇬🇧
Oxford Eye Hospital, Oxford, Oxfordshire, United Kingdom
Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2018-04-25
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 43
- Registration Number
- NCT01171378
- Locations
- 🇬🇧
St Bartholomew's Hospital, London, United Kingdom
🇬🇧Kings College Hospital, London, United Kingdom
🇬🇧Churchill Hospital, Oxford, United Kingdom